DEINOVE benefits from an experienced management team in research, development, finance and business development, a panel of high-level scientific experts and a Board of Directors highly qualified in the development of drugs and specialty compounds. This organization enables DEINOVE to develop an effective strategy that is relevant to the environment in which it operates.
Dr Charles Woler, Chairman
MD, PhD in clinical pharmacology, MBA
Alexis Rideau, Chief Executive Officer
PhD in Molecular and Cellular Biology, European Magister in Genetics, MBA
Mario Alcaraz, Chief Financial and Administrative Officer
Master in Management Sciences and Management Control, Diploma in Accounting & Management, MBA
Georges Gaudriault, Chief Scientific Officer
PhD in molecular pharmacology
Dr Yannick Plétan, Chief Medical Officer
MD, MSc, FFPM, Harvard Business School, HEC
Johane Rinaldi, Chief Human Resources Officer
University of Lyon 2, University of Bordeaux 3